pharmacia llc 100 route 206 north - nse india...pharmacia llc 100 route 206 north peapack, ny 07977...

PHARMACIA LLC 100 Route 206 North Peapack, NY 07977

April 1, 2020

The Corporate Relationship Department The Manager, Listing Department, BSE Ltd. The National Stock Exchange of India Ltd. 1st Floor, P.J. Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No. C/1, G Block, Mumbai - 400 001. Bandra – Kurla Complex, Bandra (E), India Mumbai - 400 051. India Script Code: 500680 Script Symbol: PFIZER

Mr. Prajeet Nair Company Secretary Pfizer Limited The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051.

Dear Sirs:

Sub: Submission under Regulation 30(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Enclosed please find the disclosure as on March 31, 2020 under Regulation 30(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in the prescribed format.

Kindly take the same on record.

Thanking you,

Yours truly, For PHARMACIA LLC (FORMERLY KNOWN AS PHARMACIA CORPORATION)

_________________ Name: Darren M. Welsh Designation: Secretary

Encl: A/a

DocuSign Envelope ID: D58FA0AE-483C-4299-9F61-D5D7852C3BC1

Disclosure in terms of Regulations 30(1) & 30(2) of SEBI (Substantial Acquisition of Shares

& Takeovers) Regulations, 2011.

1. Name of the Target Company (TC) Pfizer Limited

2. Name(s) of the stock exchange(s) where the

shares of the TC are listed National Stock Exchange of India Limited

BSE Limited

3. Particulars of the Shareholder(s):

a. Name of person(s) together with person Acting

in concert (PAC) whose total holding (including

that in the form of shares, warrants, convertible

securities and any other instrument that would

entitle the holder to receive shares in the TC) is

more than 25% of the voting rights of the TC

or

f. Name(s) of promoter(s), member of

the promoter group and PAC with him. Promoter

1. Pharmacia LLC

(formerly known as Pharmacia Corporation)

100 Route 206 North, Peapack

New Jersey 07977

U.S.A.

Members of the promoter group

1. Wyeth Holdings LLC

(Formerly known as Wyeth Holdings Corporation)

235 East 42nd Street

New York, New York 10017

United States

2. Wyeth LLC



United States

3. Warner-Lambert Company LLC235 East 42nd Street


U.S.A.

4. Parke, Davis & Company LLC



U.S.A.

5. John Wyeth & Brother Limited,Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom

6. Pfizer East India B.V.

Rivium Westlaan 142,

2909 LD Capelle Aan Den Ijssel,

The Netherlands

Person Acting in Concert

1. Pfizer Inc.




4. Particulars of the Shareholding of Person(s)

mentioned at 3. b. above as of March 31, 2020

Number of shares % w.r.t total

share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Pharmacia LLC 783941 1.71 1.71**



2. Wyeth LLC

3. Warner-Lambert Company LLC



6. John Wyeth & Brother Limited

Person Acting in Concert 1. Pfizer Inc.

1630164

5617707

1187163

955733

18186334

882000

Nil

3.56

12.28

2.60

2.09

39.75

1.93

Nil

3.56

12.28

2.60

2.09

39.75

1.93

Nil

Total 29243042 63.92 63.92

b. Voting Rights (otherwise than by

shares)

c. Warrants

d. Convertible Securities

e Any other instrument that would entitle the

holder to receive shares in TC

Promoter

1. Pharmacia LLC



2. Wyeth LLC






1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil

* Diluted share / voting capital means the total number of shares in the TC assuming full conversion of the

outstanding convertible securities / warrants into equity shares of the TC.

** The Target Company has not issued any convertible securities/warrants till date.

For PHARMACIA LLC

(FORMERLY KNOWN AS PHARMACIA CORPORATION)

_________________

Name: Darren M. Welsh

Designation: Secretary

Place: Hampton, NJ U.S.A

Date: April 1, 2020


Part-B***

Name of the Target Company: Pfizer Limited

Name(s) of the acquirer and

Persons Acting in Concert

(PAC) with the acquirer

Whether the acquirer

belongs to Promoter/

Promoter group

PAN of the acquirer

and/ or PACs

Pharmacia LLC Yes

John Wyeth & Brother

Limited

Yes

Wyeth Holdings LLC Yes

Warner-Lambert Company

LLC

Yes

Pfizer East India B.V. Yes

Wyeth LLC Yes

Parke, Davis & Company

LLC

Yes

Pfizer Inc. Yes

For PHARMACIA LLC

(FORMERLY KNOWN AS PHARMACIA CORPORATION)

_________________

Name: Darren M. Welsh


Place: Hampton, NJ U.S.A

Date: April 1, 2020


WARNER-LAMBERT COMPANY LLC 235 East 42nd Street New York, NY 10017

April 1, 2020



Dear Sirs:




Thanking you,

Yours truly, For WARNER-LAMBERT COMPANY LLC

________________ Name: Susan Grant Designation: Secretary

Encl: A/a







BSE Limited








or

b. Name(s) of promoter(s), member of





U.S.A.





The Netherlands

2. Wyeth LLC



United States





United States




U.S.A.

5. Pharmacia LLC



New Jersey 07977

U.S.A.

6. John Wyeth & Brother Limited,

Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom


1. Pfizer Inc.







share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Warner-Lambert Company LLC 1187163 2.60 2.60**



2. Wyeth LLC




6. Pharmacia LLC

Person Acting in Concert 1 Pfizer Inc.

18186334

5617707

1630164

955733

882000

783941

Nil

39.75

12.28

3.56

2.09

1.93

1.71

Nil

39.75

12.28

3.56

2.09

1.93

1.71

Nil

Total 29243042 63.92 63.92


shares)

c. Warrants




Promoter




2. Wyeth LLC



5. Pharmacia LLC



1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil




FOR WARNER-LAMBERT COMPANY LLC.

_________________

Name: Susan Grant


Place: Wayne, NJ U.S.A

Date: April 1, 2020


Part-B***







Promoter group

PAN of the acquirer

and/ or PACs


LLC

Yes




Limited

Yes

Wyeth LLC Yes


LLC

Yes

Pharmacia LLC Yes

Pfizer Inc. Yes

FOR WARNER-LAMBERT COMPANY LLC.

_________________

Name: Susan Grant



Date: April 1, 2020


WYETH HOLDINGS LLC 235 East 42nd Street New York, NY 10017

April 1, 2020



Dear Sirs:




Thanking you,

Yours truly, For WYETH HOLDINGS LLC (FORMERLY KNOWN AS WYETH HOLDINGS CORPORATION)

_________________ Name: Susan Grant Designation: Vice President and Secretary

Encl: A/a







BSE Limited








or

d. Name(s) of promoter(s), member of


1. Wyeth Holdings LLC(Formerly known as Wyeth Holdings Corporation)



United States





The Netherlands

2. Wyeth LLC



United States



U.S.A.




U.S.A.

5. Pharmacia LLC



New Jersey 07977

U.S.A.


Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom


1. Pfizer Inc.







share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Wyeth Holdings LLC 1630164 3.56 3.56**



2. Wyeth LLC




6. Pharmacia LLC

Person Acting in Concert 1 Pfizer Inc.

18186334

5617707

1187163

955733

882000

783941

Nil

39.75

12.28

2.60

2.09

1.93

1.71

Nil

39.75

12.28

2.60

2.09

1.93

1.71

Nil

Total 29243042 63.92 63.92


shares)

c. Warrants




Promoter




2. Wyeth LLC



5. Pharmacia LLC



1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil




For WYETH HOLDINGS LLC

(FORMERLY KNOWN AS WYETH HOLDINGS CORPORATION)

_________________

Name: Susan Grant

Designation: Vice President and Secretary


Date: April 1, 2020


Part-B***







Promoter group

PAN of the acquirer

and/ or PACs




LLC

Yes


Limited

Yes

Wyeth LLC Yes


LLC

Yes

Pharmacia LLC Yes

Pfizer Inc. Yes

For WYETH HOLDINGS LLC

(FORMERLY KNOWN AS WYETH HOLDINGS CORPORATION)

_________________

Name: Susan Grant

Designation: Vice President and Secretary


Date: April 1, 2020


WYETH LLC 235 East 42nd Street New York, NY 10017

April 1, 2020



Dear Sirs:




Thanking you,

Yours truly, For WYETH LLC

_________________ Name: Susan Grant Designation: Secretary

Encl: A/a







BSE Limited








or

c. Name(s) of promoter(s), member of


1. Wyeth LLC



United States





The Netherlands




U.S.A.





United States




U.S.A.

5. Pharmacia LLC



New Jersey 07977

U.S.A.


Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom


1. Pfizer Inc.







share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Wyeth LLC 5617707 12.28 12.28**







6. Pharmacia LLC


18186334

1187163

1630164

955733

882000

783941

Nil

39.75

2.60

3.56

2.09

1.93

1.71

Nil

39.75

2.60

3.56

2.09

1.93

1.71

Nil

Total 29243042 63.92 63.92


shares)

c. Warrants




Promoter

1. Wyeth LLC






5. Pharmacia LLC



1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil




FOR WYETH LLC

_________________

Name: Susan Grant



Date: April 1, 2020


Part-B***







Promoter group

PAN of the acquirer

and/ or PACs

Wyeth LLC Yes




Limited

Yes


LLC

Yes


LLC

Yes

Pharmacia LLC Yes

Pfizer Inc. Yes

FOR WYETH LLC

_________________

Name: Susan Grant



Date: April 1, 2020


April t, 2020

The Corporate Relationship Department

BSE Ltd.

lndia Ltd.ft Floor, P.J. Towers,Dalal StreeqMumbai - 400 001.lndiaScript Code:500680

lohn Wyeth & Brother LimitedRamsgate Road,

Sandwich,Kent,

CT13 9NJUnited Kingdom

The Manager, Listing DePartment,

The National Stock Exchange of

Exchange Plaza, 5th Floor,

Plot No. C/L,G Block,Bandra - Kurla ComPlex, Bandra (E),Mumbai- 400 051. lndiaScript Symbol: PFIZER

Mr. Prajeet NairCompany Secretary

Pfizer LimitedThe Capital, 1802 / L9AI,Plot No. C - 70, G Block, Bandra KurlaComplex, Bandra (East), Mumbai 400

051.

Dear Sirs:

sub: submission under Regulation 30(31 of the sEBl (substantialAcquisition of shares and Takeoversl Regulations,2011

Enclosed please find the disclosure as on March 31, 2o2o under Regulation

3O(3) of the sEBl (substantial Acquisition of shares and Takeovers) Regulations,

2011 in the Prescribed format.


Thanking you,

Yours trulY,For JOHN l,tYETH & BROTHER LIMITED

6Jtr\\-'\Dl,t-t^

Name: J A MOUNT

Designation: Director

Encl: A,/a

Disclosure in terms of Regulations 30(1) & 30(2) of SEBI (Substantial Acquisition ofShares & Takeovers) Reeulations. 2011.


2. Name(s) of the stock exchange(s) where theshares of the TC are listed

. National Stock Exchange of India Limitedr BSE Limited


a. Name of person(s) together with person Actingin concert (PAC) whose total holding(including that in the form of shares, warrants,convertible securities and any other inskumentthat would entitle the holder to receive sharesin the TC) is more than 25o/o of the votingrights ofthe TC

orb. Name(s) of promote(s), member of

the promoter group and PAC with him.Promoter

l. John V/yeth & Brother Limited,Ramsgate Road,Sandwich, KentCT13 9NJUnited Kingdom


1. Wyeth Holdings LLC(Formerly known as Wyeth Holdings Corporation)235 East 42nd StreetNew York, New Yor*United States

Z. Wyeth LLC235 East 42nd StreetNew York, New YorkUnited States

10017

10017

J. Wamer-Lambert Company LLC235 East 42nd StreetNew York, New York 10017U.S.A.

Parke, Davis & Company LLC235 East 42"d StreetNewYor*,NewYor* 10017U.S.A.

Pharmacia LLC(formerly known as Pharmacia Corporation)100, Route 206 NortlL PeapackNew Jersey A7977U.S.A-

5

6. Pfrzer East India B.V.Rivium Westlaan 142,29A9LD Capelle Aan Den Ijssel,Ths Netherlands


l. Pfizerlnc.235 East 42nd StreetNew York, New Yor{< 10017

4. Particulars of the Shareholdirg of Person(s)mentioned at 3. b. aborre as of March 3L,202O.

Number of shares Yo w.r.t totalshare lvatingcapitalwherenerapplicable

olo of totaldiluted share Ivoting capitalof TC (*)

a. Shares

Promoterl. John Wyeth & Brother Limited 882000 1.93 I.93**

Members of the promoter groupl. Wyeth Holdings LLC2. Wyeth LLC3. Warner-Lambert Company LLC4. Parke, Davis & Company LLC5. Pfrzer East India B.Y.6. Pharmacia LLC

Person Acting in Concert1. PfizerInc.

163016456t7707I 18716395s733

18186334783941

Nil

3.56t2.282.602.09

39.75r.7t

Nil

3.5612.282.602.09

39.75r.7l

Nil

Total 29243A42 63.92 63.92

c.d.

Voting Rights (otherwise than byshares)

WarrantsConvertible Secu ritiesAny other instrument that would entitle theholder to receive shares in TC

Promoter1. JohnWyeth & Brother Limit€d

Members of the promoter group1. Wyeth Holdings LLC2. Wyeth LLC3. Wamer-Lambert Company LLC4. Parke, Davis & Company LLC5. Pharmacia LLC

Nil

NilNilNilNilNil

Nil

NilNilNilNilNil

Nil

NilNilNitNi1Nil


Person Acting in Concertl. PfizerInc.

Nil

Nil

Nil

Nil

NiI

Nil

Total Nir Nir Nit

* Diluted share / voting capital means the total number of shares in the TC assuming full conversion ofthe outstanding convertible securities / warrants into equity shares of the TC.** The Target Company has not issued any convertible securities/warrants till date.

For JOHN WYETH & BROTHER LIIVtrTEI)

f,ftN-.^^-r\Name: J A MOUNTDesignation: DIRECTOR

Place: Tadworth, EnglandDate: April 1,2020

Part-B***


Name(s) of the acquirer and Whether the acquirer Persons Acting in Concert belongs to Promoter/ (PAC) with the acquirer Promoter group

John Wyeth & Brother Yes Limited


Warner-Lambert Company Yes LLC


Wyeth LLC Yes

Parke, Davis & Company Yes LLC

Pharmacia LLC Yes

Pfizer Inc. Yes

For JOHN WYETH & BROTHER LIMITED

Name: J A MOUNT Designation: DIRECTOR

Place: Tadworth, England

Date: April 1, 2020

PAN oftbe acquirer and/ or PACs

PARKE, DAVIS & COMPANY LLC 235 East 42nd Street New York, NY 10017

April 1, 2020 The Corporate Relationship Department The Manager, Listing Department, BSE Ltd. The National Stock Exchange of India Ltd. 1st Floor, P.J. Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No. C/1, G Block, Mumbai - 400 001. Bandra – Kurla Complex, Bandra (E), India Mumbai - 400 051. India Script Code: 500680 Script Symbol: PFIZER Mr. Prajeet Nair Company Secretary Pfizer Limited The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051.

Dear Sirs:


Enclosed please find the disclosure as on March 31, 2020 under Regulation 30(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in the prescribed format. Kindly take the same on record.

Thanking you,

Yours truly, For PARKE, DAVIS & COMPANY LLC _________________

Name: Susan Grant Designation: Secretary

Encl: A/a




1. Name of the Target Company (TC)

Pfizer Limited


shares of the TC are listed

National Stock Exchange of India Limited

BSE Limited








or

e. Name(s) of promoter(s), member of the promoter group and PAC with him.

Promoter




U.S.A.






United States

2. Wyeth LLC



United States

3. Warner-Lambert Company LLC 235 East 42nd Street


U.S.A.




The Netherlands

5. Pharmacia LLC



New Jersey 07977

U.S.A.


Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom


1. Pfizer Inc.







share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Parke, Davis & Company LLC 955733 2.09 2.09**



2. Wyeth LLC




6. Pharmacia LLC


1630164

5617707

1187163

18186334

882000

783941

Nil

3.56

12.28

2.60

39.75

1.93

1.71

Nil

3.56

12.28

2.60

39.75

1.93

1.71

Nil

Total 29243042 63.92 63.92


shares)

c. Warrants




Promoter




2. Wyeth LLC



5. Pharmacia LLC



1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil




For PARKE, DAVIS & COMPANY LLC

_________________

Name: Susan Grant



Date: April 1, 2020


Part-B***







Promoter group

PAN of the acquirer

and/ or PACs


LLC

Yes




LLC

Yes


Limited

Yes

Wyeth LLC Yes

Pharmacia LLC Yes

Pfizer Inc. Yes

For PARKE, DAVIS & COMPANY LLC

_________________

Name: Susan Grant



Date: April 1, 2020


Pfizer East India B.V. PO box 37 2900 AA Capelle aan den IJssel The Netherlands

tel. 31 (0)10 4064 2 Rivium Westlaan 14 2909 LD Capelle aan den Ijssel The Netherlands

fax 31 (0)10 4064 299 C.o.C. nr. 55055494



Date : April 1, 2020

Subject : Submission under Regulation 30(3) of the SEBI (Substantial Acquisition of

Shares and Takeovers) Regulations, 2011.

Dear sir, madam,



Thanking you,

Kind regards,

Pfizer East India B.V.

Eduard Slijkoord Managing Director B

DocuSign Envelope ID: CA1E9CCA-F1C9-44F1-A11F-B0F1C227CCC1






BSE Limited








or

b. Name(s) of promoter(s), member of




2909 LD Capelle aan den IJssel,

The Netherlands






United States

2. Wyeth LLC



United States



U.S.A.




U.S.A.

5. Pharmacia LLC


100, Route 206 North, Peapack

New Jersey 07977

U.S.A.


Ramsgate Road,

Sandwich, Kent,

CT13 9NJ

United Kingdom


1. Pfizer Inc.





mentioned at 3. b. above as of March 31, 2020.


share / voting

capital

wherever

applicable

% of total

diluted share /

voting capital

of TC (*)

a. Shares

Promoter

1. Pfizer East India B.V. 18186334 39.75 39.75**



2. Wyeth LLC




6. Pharmacia LLC


1630164

5617707

1187163

955733

882000

783941

Nil

3.56

12.28

2.60

2.09

1.93

1.71

Nil

3.56

12.28

2.60

2.09

1.93

1.71

Nil

Total 29243042 63.92 63.92


shares)

c. Warrants




Promoter




2. Wyeth LLC



5. Pharmacia LLC



1. Pfizer Inc.

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Nil

Total Nil Nil Nil




For PFIZER EAST INDIA B.V.

_________________

Name: Eduard Slijkoord

Designation: managing director B

Place: Capelle aan den IJssel,

Date: April 1, 2020


Part-B***







Promoter group

PAN of the acquirer

and/ or PACs




LLC

Yes


Limited

Yes

Wyeth LLC Yes


LLC

Yes

Pharmacia LLC Yes

Pfizer Inc. Yes

For PFIZER EAST INDIA B.V.

_________________

Name: Eduard Slijkoord

Designation: managing director B

Place: Capelle aan den IJssel,

Date: April 1, 2020



PfizerLimitedPfizerLimited1PfizerLimited2PfizerLimited3PfizerLimited4PfizerLimited5PfizerLimited6

pharmacia llc 100 route 206 north - nse india...pharmacia llc 100 route 206 north peapack, ny 07977...

Documents